Mayo Clinic methotrexate monitoring trial, rheumatic diseases

The National Library of Medicine registered a new clinical trial (NCT07512401) on ClinicalTrials.gov. The study, sponsored by Mayo Clinic, will investigate methotrexate monitoring practices in patients with rheumatic diseases. The trial is currently recruiting participants at Mayo Clinic locations in Arizona and Minnesota.

CAR-NK Cell Therapy Trial for HER2+ Breast Cancer

ClinicalTrials.gov registered a Phase I/II clinical trial (NCT07510802) evaluating CAR-NK cell therapy for HER2+ breast cancer. The trial is sponsored by a Beijing-based biotechnology company. This registry entry provides public disclosure of ongoing research but does not establish new regulatory obligations.

Zhejiang University Thiotepa trial for meningeal-risk Glioblastoma

The National Library of Medicine registered clinical trial NCT07511725 on ClinicalTrials.gov. The trial, sponsored by Zhejiang University, evaluates Thiotepa treatment for meningeal-risk Glioblastoma. ClinicalTrials.gov serves as a public registry for clinical research studies meeting registration requirements under FDAAA 801.

Oxford wearable tech study, transfusion patients, blood cancers

The National Library of Medicine registered a new clinical study (NCT07511829) on ClinicalTrials.gov conducted by Oxford University. The study will evaluate wearable technology in patients with blood cancers who require transfusions. Registration fulfills federal requirements for clinical trial reporting.

OPKO Health OPK-88006 Phase 1/2 Clinical Trial Registration

ClinicalTrials.gov registered a Phase 1/2 clinical trial (NCT07512427) sponsored by OPKO Health evaluating OPK-88006. The study registration provides standard protocol details including eligibility criteria, study design, and investigator information. ClinicalTrials.gov is maintained by the National Library of Medicine under NIH.

Brain Stimulation for Mild Cognitive Impairment

The National Library of Medicine registered a new clinical trial (NCT07512193) on ClinicalTrials.gov. The study, sponsored by Johns Hopkins University, will evaluate brain stimulation as an intervention for mild cognitive impairment.

FTC Monetary Remedies and Data-Driven Economy Podcast Discussion

The ABA Antitrust Law Section published a podcast discussion featuring former FTC economists and staff examining monetary remedies available to the FTC in data-driven economy enforcement actions. The panel analyzes how the FTC calculates and structures monetary relief in cases involving digital markets, privacy violations, and deceptive practices.

Credit agency wins FCRA case, no actionable harm

Credit agency wins FCRA case, no actionable harm

Credit Agreement Implications of Supreme Court Tariff Decision

Orrick, Herrington & Sutcliffe LLP analyzes credit agreement implications following the Supreme Court's February 20, 2026 ruling invalidating IEEPA tariffs. The analysis addresses accounting treatment of potential refunds under FASB ASC 410-30 and ASC 450, and covers impacts on interest margins, financial covenants, incurrence tests, and extraordinary receipts provisions. Borrowers with existing credit facilities should evaluate these developments with their accountants and lenders.

When Participant Growth Becomes a Fiduciary Prompt — Not a Punchline

The Rosenbaum Law Firm published an analysis warning retirement plan sponsors that participant growth metrics do not equate to fiduciary compliance. The article uses Empower's reported addition of 500,000 net new retirement plan participants as context to highlight that larger participant populations increase operational complexity, testing nuances, and probability of service breakdowns.